Here, we report that ILEI contributes to melanoma cell line invasiveness in vivo and build on our previous finding that vemurafenib (BRAFi) decreases ILEI mRNA expression to characterize the molecular details of ILEI transcriptional regulation by USF-1 (25). The gene discussed is FAM3C; the disease is melanoma.